Professeur CHRISTOPHE RICHEZ
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Direction de thèses
🎓 2 thèses dirigéesLes sélectines inhibent la fonction des lymphocytes T régulateurs et contribuent à la pathogénie du lupus érythémateux systémique
2020Doctorant·e : Marc Scherlinger
Microbiologie -immunologie🎓 BordeauxPropriétés immuno-modulatrices des IgE dans le lupus érythémateux systémique : impact sur la sécrétion d’interféron de type I par les cellules dendritiques plasmacytoïdes
2014Doctorant·e : Liliane Khoryati
Microbiologie-Immunologie🎓 Bordeaux
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
50
h articles cités ≥ h fois chacun. Un h de 50 = 50 publications avec 50+ citations.
Citations
10 463
Publications
415
i10-index
140
Thématiques principales
- Systemic Lupus Erythematosus Research ×133
- Rheumatoid Arthritis Research and Therapies ×124
- Spondyloarthritis Studies and Treatments ×41
- Autoimmune and Inflammatory Disorders Research ×35
- Systemic Sclerosis and Related Diseases ×34
Affiliations FR : Centre National de la Recherche Scientifique · Université de Bordeaux · Centre Hospitalier Universitaire de Bordeaux
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026ArticleRMD Open
Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases
2026ArticleEBioMedicine
Prevalence of effective contraceptive use among patients with rheumatic diseases: a descriptive study
2026ArticleBMC Rheumatology
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025ArticleThe Lancet Rheumatology
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica
2025ArticleArthritis & rheumatology
Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
2025ArticleDrug Safety
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2025ArticleACR Open Rheumatology
Anti-CD20 alone as maintenance immunosuppressive therapy in severe lupus nephritis: a promising experience that needs to be evaluated
2025ArticleLupus science & medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
GROUPE HOSPITALIER PELLEGRIN - CHU
Place AMELIE RABA LEON, 33076 Bordeaux
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Articles de presse (1)
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
- Rencontre avec Marc Scherlinger – lauréat Atip-Avenir - Inserm
📰 Inserm · 02/08/2023
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxNWWRRYTlYRDZGcDU3QTlZQzRQMDRJX0FPclhCb2g3X3I1TU4yWVRoS3QtVDBwYUJ6eHFYUlFuSTNtRnJITVlwUDBsaG1GM29PN3lwVWdwaExSZnVCaUlMMGZJZEhUWTg5VGRhNDdNTnZsczZGc3lZQ1h1Y1RTdURJSVFsRldrSmV2ZlRMaQ?oc=5" target="_blank">Rencontre avec Marc Scherlinger – lau
Top publications · les plus citées
- 2CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
The Lancet. Rheumatology · 2025
📚 28 citations🎯 RCR 10.18 - 3Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
The Lancet. Rheumatology · 2025
📚 14 citations🎯 RCR 5.85🩺 Clinique
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal24
▼
Transversal24
▼- Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
RMD open · 2026 · Journal Article
Hornez M, Molto A, Leroy M, Banneville B, et al.
- Cervical cancer screening practices among patients with autoimmune and inflammatory rheumatic diseases: a descriptive cross-sectional observational study
BMC women's health · 2026 · Journal Article
Delattre C, Uthuriague M, Barnetche T, Lambert M, et al.
- Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
Joint bone spine · 2026 · Journal Article
Juge PA, Debray MP, Pensec VD, Richez C, et al.
- [Sustainable healthcare transition: A guide for deprescribing unnecessary biological tests]
La Revue de medecine interne · 2026 · Editorial
Costedoat-Chalumeau N, Bortolotti V, Michon A, Cariou PL, et al.
- Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
Annals of the rheumatic diseases · 2026 · Journal Article
Hamroun S, de Frémont GM, Costedoat-Chalumeau N, Couderc M, et al.
- Skin cancer risk in patients with non-dermatologic immune-mediated inflammatory diseases
Joint bone spine · 2026 · Journal Article
Letarouilly JG, Wils P, Staumont-Sallé D, Jullien D, et al.
- Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease
The European respiratory journal · 2025 · Journal Article
El Husseini K, Lee JS, Juge PA, Ebstein E, et al.
📚 1 cit.🩺 Clinique - CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
The Lancet. Rheumatology · 2025 · Journal Article
Scherlinger M, Nocturne G, Radic M, Launay D, et al.
📚 28 cit.🎯 RCR 10.18🔬→🩺 Translationnel - Anti-CD20 alone as maintenance immunosuppressive therapy in severe lupus nephritis: a promising experience that needs to be evaluated
Lupus science & medicine · 2025 · Letter
Boutinet S, Lebourg L, Faguer S, Richez C, et al.
- Disease activity during pregnancy in patients with rheumatoid arthritis or spondyloarthritis: results from the multicentre prospective GR2 study
BMC rheumatology · 2025 · Journal Article
Couderc M, Lambert C, Hamroun S, Gallot D, et al.
📚 1 cit. - Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab
RMD open · 2025 · Letter
Trefond L, Chasset F, Jachiet M, Livideanu C, et al.
📚 6 cit.🎯 RCR 2.28🔬→🩺 Translationnel - Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
La Revue de medecine interne · 2025 · Journal Article
de Boysson H, Devauchelle-Pensec V, Agard C, André M, et al.
📚 2 cit.🩺 Clinique - French protocol for the diagnosis and management of giant cell arteritis
La Revue de medecine interne · 2025 · Journal Article
de Boysson H, Devauchelle-Pensec V, Agard C, André M, et al.
📚 12 cit.🎯 RCR 4.97🔬→🩺 Translationnel - Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study
Joint bone spine · 2025 · Journal Article
Ladouceur A, Barnetche T, Prey S, Dutriaux C, et al.
📚 4 cit.🩺 Clinique - 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
Joint bone spine · 2024 · Journal Article
Fautrel B, Kedra J, Rempenault C, Juge PA, et al.
📚 10 cit.🎯 RCR 2.84🔬→🩺 Translationnel - Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
Clinical and experimental rheumatology · 2024 · Journal Article
Ruyssen-Witrand A, Dimeglio C, Nogue E, Molinary N, et al.
- Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic intervillositis of unknown etiology
Nature communications · 2024 · Journal Article
Mattuizzi A, Sauvestre F, Fargeix T, White E, et al.
📚 13 cit.🎯 RCR 3.37 - Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024 · Journal Article
Driouich JS, Cochin M, Lingas G, Luciani L, et al.
📚 2 cit. - Concordance and agreement between different activity scores in polymyalgia rheumatica
RMD open · 2024 · Randomized Controlled Trial
D'Agostino J, Souki A, Lohse A, Carvajal Alegria G, et al.
📚 5 cit.🎯 RCR 1.45🩺 Clinique - Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study
Seminars in arthritis and rheumatism · 2024 · Multicenter Study
Chehem Daoud Chehem F, de Mornac D, Feuillet F, Liozon E, et al.
📚 8 cit.🎯 RCR 1.82 - Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort
Joint bone spine · 2023 · Multicenter Study
Perrot L, Boyer L, Flipo RM, Marotte H, et al.
📚 1 cit.🔬→🩺 Translationnel - Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
RMD open · 2023 · Observational Study
Ladouceur A, Barnetche T, Mouterde G, Tison A, et al.
📚 5 cit.🩺 Clinique - Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment
Scientific reports · 2023 · Journal Article
Avouac J, Vandebeuque E, Combier A, Poiroux L, et al.
📚 4 cit. - Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
Joint bone spine · 2023 · Letter
Drumez E, Richez C, Bebear L, Herasse M, et al.
📚 1 cit.
Lupus9
▼
Lupus9
▼- Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases
EBioMedicine · 2026 · Journal Article
Tusseau M, Khaldi-Plassart S, Labalme A, Mathieu AL, et al.
- Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus
Expert review of clinical pharmacology · 2025 · Journal Article
Uthurriague M, Lazaro E, Richez C, Blanco P, et al.
- ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations
The Lancet. Rheumatology · 2025 · Journal Article
Arnaud L, Ruiz-Irastorza G, Aranow C, Bernatsky S, et al.
📚 4 cit. - Safety of Fertility Treatments in Women With Systemic Lupus Erythematosus: Data From a Prospective Population-Based Study
BJOG : an international journal of obstetrics and gynaecology · 2025 · Journal Article
Dernoncourt A, Guettrot-Imbert G, Sentilhes L, Besse MC, et al.
📚 1 cit.🩺 Clinique - Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients
Rheumatology (Oxford, England) · 2025 · Journal Article
Alle G, Guettrot-Imbert G, Larosa M, Murarasu A, et al.
📚 8 cit.🎯 RCR 3.72🩺 Clinique - No Effect of Low-Dose Glucocorticoid Maintenance Therapy on Damage in SLE Patients in Prolonged Remission: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort
Journal of clinical medicine · 2024 · Journal Article
Ruiz-Irastorza G, Paredes-Ruiz D, Dueña-Bartolome L, Hernandez-Negrin H, et al.
📚 3 cit. - French protocol for the diagnosis and management of systemic lupus erythematosus
La Revue de medecine interne · 2024 · Journal Article
Amoura Z, Bader-Meunier B, Antignac M, Bardin N, et al.
📚 9 cit.🎯 RCR 2.43 - Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort
Arthritis care & research · 2024 · Journal Article
Ruiz-Irastorza G, Paredes-Ruiz D, Herrero-Galvan M, Moreno-Torres V, et al.
📚 11 cit.🎯 RCR 2.95🩺 Clinique - Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus
Expert review of clinical immunology · 2024 · Journal Article
Gensous N, Lazaro E, Blanco P, Richez C
📚 14 cit.🎯 RCR 2.66
Épidémiologie & registres5
▼
Épidémiologie & registres5
▼- Prevalence of effective contraceptive use among patients with rheumatic diseases: a descriptive study
BMC rheumatology · 2026 · Journal Article
Uthurriague M, Delattre C, Barnetche T, Lazaro E, et al.
- Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases
Rheumatology (Oxford, England) · 2024 · Journal Article
Thomas M, Masson M, Bitoun S, Hamroun S, et al.
📚 5 cit.🩺 Clinique - Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry
Rheumatology (Oxford, England) · 2024 · Journal Article
Faganello D, Bertrand A, Meunier P, Avouac J, et al.
📚 2 cit. - Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry
The Journal of infection · 2024 · Journal Article
Caillet Portillo D, Puéchal X, Masson M, Kostine M, et al.
📚 10 cit.🎯 RCR 3.31 - Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry
Arthritis care & research · 2024 · Journal Article
Yazdany J, Ware A, Wallace ZS, Bhana S, et al.
📚 8 cit.🎯 RCR 1.58
JAK inhibiteurs3
▼
JAK inhibiteurs3
▼- Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
The Lancet. Rheumatology · 2025 · Clinical Trial, Phase II
Saraux A, Carvajal Alegria G, Dernis E, Roux C, et al.
📚 14 cit.🎯 RCR 5.85🩺 Clinique - Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
ACR open rheumatology · 2025 · Journal Article
Wollenhaupt J, Morel J, Daien C, Ruyssen-Witrand A, et al.
📚 1 cit. - Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
Annals of the rheumatic diseases · 2023 · Clinical Trial, Phase III
Fleischmann R, Curtis JR, Charles-Schoeman C, Mysler E, et al.
📚 44 cit.🎯 RCR 5.74🩺 Clinique
Pharmacovigilance3
▼
Pharmacovigilance3
▼- Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
Drug safety · 2025 · Published Erratum
Di Napoli R, Richez C, Scavone C, Singier A, et al.
📚 1 cit. - Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
Drug safety · 2025 · Published Erratum
Di Napoli R, Richez C, Scavone C, Singier A, et al.
📚 1 cit. - Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
Drug safety · 2025 · Journal Article
Di Napoli R, Richez C, Scavone C, Singier A, et al.
📚 7 cit.🎯 RCR 2.76
Biothérapies non-anti-TNF2
▼
Biothérapies non-anti-TNF2
▼- Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Chevet B, Souki A, Nowak E, Carvajal-Alegria G, et al.
📚 1 cit.🩺 Clinique - Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
BMJ open · 2025 · Clinical Trial Protocol
Pascart T, Fautrel B, Gottenberg JE, Ducoulombier V, et al.
🩺 Clinique
csDMARDs2
▼
csDMARDs2
▼- Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
The Lancet. Rheumatology · 2025 · Journal Article
Morel J, Dernis E, Roux C, Richez C, et al.
📚 2 cit.🩺 Clinique - Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients
Rheumatology (Oxford, England) · 2025 · Journal Article
Alle G, Guettrot-Imbert G, Larosa M, Murarasu A, et al.
📚 8 cit.🎯 RCR 3.72🩺 Clinique
AINS1
▼
AINS1
▼- NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort
RMD open · 2024 · Journal Article
Hamroun S, Couderc M, Flipo RM, Sellam J, et al.
📚 4 cit.🎯 RCR 1.25🩺 Clinique
Corticothérapie1
▼
Corticothérapie1
▼- Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Annals of the rheumatic diseases · 2025 · Journal Article
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, et al.
📚 8 cit.🎯 RCR 3.62🩺 Clinique
Essai clinique1
▼
Essai clinique1
▼- Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Annals of the rheumatic diseases · 2025 · Journal Article
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, et al.
📚 8 cit.🎯 RCR 3.62🩺 Clinique
Génétique1
▼
Génétique1
▼- Anifrolumab: the new frontier in the treatment of genetic interferonopathies
RMD open · 2024 · Editorial
Frémond ML, David C, Richez C
📚 5 cit.
Risque cardio-vasculaire1
▼
Risque cardio-vasculaire1
▼- Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
Annals of the rheumatic diseases · 2023 · Clinical Trial, Phase III
Fleischmann R, Curtis JR, Charles-Schoeman C, Mysler E, et al.
📚 44 cit.🎯 RCR 5.74🩺 Clinique
Datasets & protocoles partagés
Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review
Collection2017FigshareAbstract Background The aim of this study was to identify the most reliable biomarkers in the literature that could be used as flare predictors in systemic lupus erythematosus (SLE). Methods A systematic review of the li
Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review
Collection2017FigshareAbstract Background The aim of this study was to identify the most reliable biomarkers in the literature that could be used as flare predictors in systemic lupus erythematosus (SLE). Methods A systematic review of the li
Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic histiocytic intervillositis of unknown etiology
Dataset2024figshareComparison of IL-1b, IL-18, NLRP3, PYCARD, CASPASE 1, MEFV gene signatures expression in healthy controls, and CHI samples
Rhumatologie
Audiovisual2010Université de Bordeaux - SAMLes Journées Victor Segalen - Université Bordeaux 2 Formation Médicale Permanente : La Journée des Généralistes Organisée dans le cadre des Journées Victor Segalen 2010 par l’Unité Mixte de Formation Continue en Santé de
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).